Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Specific compatibility considerations include confirmation of absence of reducing agents for disulphide-containing peptides, BSA carrier supplementation for recombinant proteins, and acetic acid acidification for hydrophobic peptides requiring low pH solubilisation
This therapy is often used to manage conditions like migraines, fibromyalgia, and chronic fatigue syndrome
Acknowledgements Author contributions: K
This material is supplied for laboratory research use only
US$ 29.77
US$ 28.49
US$ 28.03
US$ 28.13
US$ 21.58
US$ 21.42
US$ 24.18
US$ 21.40
